The Centers for Medicare & Medicaid Services (CMS) announced on Monday a significant increase in payment rates for Medicare Advantage (MA) plans in 2027, reversing an earlier proposal and sending insurer stocks soaring. The finalized policy raises payments by an average of 2.48%, amounting to $13 billion in additional funding, far exceeding the 0.09% increase initially proposed in January.
Stock Market Reaction
Shares of major insurers, including UnitedHealth Group, Humana, and CVS Health, surged on Tuesday following the announcement. UnitedHealth rose 8%, Humana 10.7%, and CVS 4%, reflecting investor optimism about the higher reimbursement rates.
Policy Rationale and Changes
CMS cited growing healthcare costs, quality bonus payments for high-performing plans, and risk adjustment updates as key factors behind the increase. The agency also emphasized efforts to reduce coding differences between original Medicare and Medicare Advantage, though these adjustments will not take effect in 2027. The changes aim to simplify administrative processes, promote fair competition, and align payments with beneficiaries' actual health risks.
Long-Term Implications
CMS framed the policy as part of a broader effort to maintain affordability and choice for seniors while ensuring fiscal responsibility. The agency stated that improving payment accuracy is essential for long-term sustainability of the Medicare Advantage program. Analysts noted that the increase reflects ongoing adjustments to improve payment accuracy and may signal a shift in regulatory approach.
Industry and Analyst Reactions
Analysts from Morningstar and Jefferies described the revision as a correction of earlier actuarial miscalculations rather than a retreat from regulatory oversight. The payment increase is expected to affect premiums, plan benefits, and insurer profitability, influencing their bids for 2027 contracts.